Chemical compound
Pharmaceutical compound
Piperidolate is a pharmaceutical drug used to treat the symptoms of gastrointestinal disorders including gastric and duodenal ulcers, gastritis, enteritis, gallstones, cholecystitis, and biliary dyskinesia.[1] It acts as an antimuscarinic agent.[2][3] It was first approved in 1954 and is no longer marketed in the United States.[1]
References
- ^ a b “Piperidolate”. Inxight Drugs. National Center for Advancing Translational Sciences.
- ^ “Piperidolate”. drugs.com.
- ^ Vardanyan R (2017). Piperidine-Based Drug Discovery. Elsevier Science. p. 130. ISBN 978-0-12-813428-3.
Drugs for functional gastrointestinal disorders (A03) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drugs for functional bowel disorders |
| ||||||||||||
| Belladonna and derivatives (antimuscarinics) |
| ||||||||||||
| Propulsives | |||||||||||||